Tools

DCA Vantage Analyzer

Drive diabetic patient compliance with trusted, clinically proven results

DCA Vantage Analyzer

    Provide the clinical confidence your patients deserve. The DCA Vantage® Analyzer helps you monitor glycemic control and detect early kidney disease in environments ranging from the physician’s office to remote, point-of-care coordinated sites in hospitals and multisite practices. Meet lab-quality testing standards with an analyzer that speeds and simplifies diabetes tests and delivers accurate,1 clinically relevant results shown to improve decision-making,2,3 patient compliance, and outcomes.4

    References
    1. Lenters-Westra E, Slingerland RJ. Clin Chem 2010;56(1):44.
    2. Thaler LM, et al. Diabetes Care 1999;22:1415-21.
    3. Miller CD, et al. Diabetes Care 2003;26:1158-63.
    4. Cagliero E, et al. Diabetes Care 1999;22:1785-9.
    5. GHX Market Intelligence, market data report. 4Q 2012 Report.

    The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

    Did this information help you?
    Thank you for your response
    We detected numbers and/or an '@' symbol in your comment. Are you trying to enter a phone number or email address so that we may contact you, please contact us via our email form instead.

    Note: to get a direct personal response, please contact us via our email form.

    Thank you